510(k) · Cleared
ClearedProdigy Blood Glucose Test System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Diagnostic Devices, Inc. · NBW System, Test, Blood Glucose, Over The Counter
Cleared on Jul 13, 2006 as substantially equivalent to K042005 (Taidoc Technology Corporation, 2004) after a 140-day review. Its family tree reaches back 1 generation to 2004. 17 later devices descend from it.
- Decided
- Jul 13, 2006
- Review
- 140 days
- Class
- Class II
- Product code
- NBW
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K042005 (2004). 17 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK042005 Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222Taidoc Technology Corporation · 2004
- This deviceK060467 Prodigy Blood Glucose Test SystemDiagnostic Devices, Inc. · 2006
- Descendant · cites it directly · 14 of its ownK073118 Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc. · 2008
- Descendant · 2 generations on · 6 of its ownK091815 Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp. · 2009
- Descendant · 2 generations on · 3 of its ownK122338 Preferred Blood Glucose Monitoring SystemProdigy Diabetes Care, LLC · 2013
- Descendant · cites it directly · 1 of its ownK160038 UniStrip1 Generic Blood Glucose Test StripsOk Biotech Co., Ltd. · 2016
- Descendant · 3 generations on · 1 of its ownK141914 Prodigy Autocode Eject Blood Glucose Monitoring SystemOk Biotech Co., Ltd. · 2015
Showing 5 of 17 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 17 · See all- K073118Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc. · 2008 · cites it directly14descendants
- K091815Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp. · 2009 · 2 generations on6descendants
- K122338Preferred Blood Glucose Monitoring SystemProdigy Diabetes Care, LLC · 2013 · 2 generations on3descendants
- K160038UniStrip1 Generic Blood Glucose Test StripsOk Biotech Co., Ltd. · 2016 · cites it directly1descendant
- K141914Prodigy Autocode Eject Blood Glucose Monitoring SystemOk Biotech Co., Ltd. · 2015 · 3 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K042005 | Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222 | Taidoc Technology Corporation | 2004 | — |
| 0 (this device) | K060467 | Prodigy Blood Glucose Test System | Diagnostic Devices, Inc. | 2006 | — |
| +1 | K073118 | Prodigy Voice Blood Glucose Monitoring System | Diagnostic Devices, Inc. | 2008 | — |
| +2 | K091815 | Supercheck 1 Blood Glucose Monitoring System, Model 6268 | Biotest Medical Corp. | 2009 | — |
| +2 | K122338 | Preferred Blood Glucose Monitoring System | Prodigy Diabetes Care, LLC | 2013 | — |
| +1 | K160038 | UniStrip1 Generic Blood Glucose Test Strips | Ok Biotech Co., Ltd. | 2016 | — |
| +3 | K141914 | Prodigy Autocode Eject Blood Glucose Monitoring System | Ok Biotech Co., Ltd. | 2015 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 4 | 0 |
| 2013 | 4 | 0 |
| 2014 | 2 | 0 |
| 2015 | 2 | 0 |
| 2016 | 2 | 0 |
| 2017 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NBW device
- #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K042005 | Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222Summary page 1…system and Quality Control Material Safety and Effective Information Predicate Device: Claim of Substantial Equivalence (SE) is made to TaiDoc Technology Corporation. K042005, Achtung TD-4207/ Clever Chek TD-4209/ Clever Chek TD-4222 Glucose Test Systems. Indications for Use: The Prodigy Blood Glucos… | 2004 |
What descends from it? (17)
See all 172 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All NBW devicesNBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · NBW
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NBW
243in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NBW
1in 2025
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · NBW
4,745in 2025
MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 29 | 85 | 9 | 7,991 |
| 2008 | 37 | 128 | 2 | 7,704 |
| 2009 | 38 | 140 | 5 | 10,963 |
| 2010 | 31 | 132 | 11 | 11,631 |
| 2011 | 30 | 328 | 1 | 22,909 |
| 2012 | 30 | 230 | 1 | 23,449 |
| 2013 | 47 | 167 | 5 (2) | 35,408 |
| 2014 | 24 | 202 | 1 | 38,524 |
| 2015 | 32 | 237 | 0 | 62,111 |
| 2016 | 20 | 233 | 1 | 76,621 |
| 2017 | 25 | 244 | 0 | 37,538 |
| 2018 | 19 | 168 | 0 | 16,911 |
| 2019 | 10 | 127 | 14 | 14,472 |
| 2020 | 7 | 121 | 0 | 10,703 |
| 2021 | 7 | 465 | 0 | 9,198 |
| 2022 | 12 | 410 | 0 | 8,103 |
| 2023 | 5 | 193 | 0 | 7,256 |
| 2024 | 7 | 243 | 0 | 6,220 |
| 2025 | 2 | — | 1 | 4,745 |
| 2026 | 5 | 190 | 0 | — |
What is it indicated for?
The Prodigy Blood Glucose Test System is intended to be used for the quantitative
measurement of glucose in capillary whole blood from the fingertip and palm. It is
intended for use by healthcare professionals and people with diabetes mellitus at home
as an aid in monitoring the effectiveness of diabetes control program. It is not intended
for the diagnosis of or screening for diabetes mellitus, and not intended for use on
neonates.
The Prodigy meter is to be used with the Prodigy Blood Glucose Test Strip, and the
Prodigy Glucose Control Solutions.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K060467 · printed Nov 4, 2026
Cite this page
510(k) Report. “K060467: Prodigy Blood Glucose Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K060467
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026